Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thrombotic microangiopathy and anti-VEGF agents.

× No keyword cloud information.

23 in total

Review 1. Thrombotic microangiopathy with targeted cancer agents.

Authors: John A Blake-Haskins; Robert J Lechleider; Robert J Kreitman
Journal: Clin Cancer Res Date: 2011-08-03 Impact factor: 12.531

Review 2. Adverse effects of anticancer agents that target the VEGF pathway.

Authors: Helen X Chen; Jessica N Cleck
Journal: Nat Rev Clin Oncol Date: 2009-07-07 Impact factor: 66.675

Review 3. Chemotherapy-associated renal dysfunction.

Authors: Vaibhav Sahni; Devasmita Choudhury; Ziauddin Ahmed
Journal: Nat Rev Nephrol Date: 2009-06-30 Impact factor: 28.314

Review 4. VEGF inhibition, hypertension, and renal toxicity.

Authors: Suzanne R Hayman; Nelson Leung; Joseph P Grande; Vesna D Garovic
Journal: Curr Oncol Rep Date: 2012-08 Impact factor: 5.075

Review 5. New insights into molecular mechanisms of diabetic kidney disease.

Authors: Shawn S Badal; Farhad R Danesh
Journal: Am J Kidney Dis Date: 2014-02 Impact factor: 8.860

Review 6. Renal toxicity of targeted therapies.

Authors: Ronan J Kelly; Bertrand Billemont; Olivier Rixe
Journal: Target Oncol Date: 2009-05-06 Impact factor: 4.493

7. VEGF inhibition and renal thrombotic microangiopathy.

Authors: Vera Eremina; J Ashley Jefferson; Jolanta Kowalewska; Howard Hochster; Mark Haas; Joseph Weisstuch; Catherine Richardson; Jeffrey B Kopp; M Golam Kabir; Peter H Backx; Hans-Peter Gerber; Napoleone Ferrara; Laura Barisoni; Charles E Alpers; Susan E Quaggin
Journal: N Engl J Med Date: 2008-03-13 Impact factor: 91.245

Thrombotic microangiopathy and anti-VEGF agents.